
Iris Broce-Diaz
Assistant Professor of Neurosciences at UC San Diego School of Medicine, developing multimodal tools for early Alzheimer's detection
4
APPEARANCES
4
PODCASTS
024
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
Aug 6, 2026
Improving Early Alzheimers Detection in Women by Integrating Multimodal Data Into Clinical Decision Tools with Iris Broce-Diaz Ph.D.
0:23
0:47
0:52
1:04
1:16
1:27


Iris Broce-DiazGUEST
well thank you so much for inviting me yeah i'm iris and i'm in the department of neurosciences so um thank you for giving me the opportunity to talk like what for six seconds for the work that i'm doing and um So I have this grant that I just recently got awarded from the Wellcome Care Lead Program.

Iris Broce-DiazGUEST
And really, their whole focus is on Alzheimer's disease prevention in women.

Iris Broce-DiazGUEST
And so Alzheimer's disease is a progressive neurodegenerative condition that impairs your memory and cognition and affects millions of people worldwide.

Iris Broce-DiazGUEST
What I'm trying to do is develop these accessible, non-invasive, cost-effective tools that can help primary care and neurologists in an early detection of Alzheimer's disease.

Iris Broce-DiazGUEST
Really, to create a tool and deploy it in the clinics and make it accessible here and worldwide, we're starting with standard of care tools.

Iris Broce-DiazGUEST
um and so what's considered standard of care is very different in a high resource center versus a low resource center versus here versus latin america versus europe and that's really interesting but we are starting here at ucsd and diagnosing dementia really does start in primary care and so usually like a patient will report a concern or the family member And then the primary care, they don't have a lot of time, but they'll order some standard labs.
8 MINS LATER
S
10:11speaker_4AUDIENCE
How do we get it that standard so that this actually makes a difference?
Improving Early Alzheimers Detection in Women by Integrating Multimodal Data Into Clinical Decision Tools with Iris Broce-Diaz Ph.D.
0:22
0:29
0:38
0:44

S
0:11speaker_0NARRATOR
Visit uctv.tv/motherhood for more.

Iris Broce-DiazGUEST
So, um, thank you for giving me the opportunity to talk, like what, for six seconds for the work that I'm doing.

Iris Broce-DiazGUEST
[laughs] And, um, so, um, I have this grant that I just recently got awarded from the Welcome Care Leap program.

Iris Broce-DiazGUEST
Um, and really, their whole focus is on Alzheimer's disease prevention in women.

Iris Broce-DiazGUEST
And so Alzheimer's disease is a progressive neurodegenerative condition that really impairs your memory and cognition and, like, affects millions of people worldwide.
9 MINS LATER
S
10:02speaker_5UNKNOWN
But how do we get it that standard so that this actually makes a difference?
Improving Early Alzheimers Detection in Women by Integrating Multimodal Data Into Clinical Decision Tools with Iris Broce-Diaz Ph.D.
0:22
0:29
0:38
0:44

S
0:11speaker_0ANNOUNCER
Visit uctv.tv/motherhood for more.

Iris Broce-DiazGUEST
So, um, thank you for giving me the opportunity to talk, like what? For six seconds for the work that I'm doing.

Iris Broce-DiazGUEST
[laughs] And, um, so, um, I have this grant that I just recently got awarded from the Welcome Care Leap program.

Iris Broce-DiazGUEST
Um, and really their whole focus is on Alzheimer's disease prevention in women.

Iris Broce-DiazGUEST
And so Alzheimer's disease is a progressive neurodegenerative condition that really impairs your memory and cognition and, like, affects millions of people worldwide.
9 MINS LATER
S
9:55speaker_5UNKNOWN
Like, how do we get it so every five years, um, some kind of risk tiering maybe based on family history or something like that? But how do we get it that standard so that this actually makes a difference?
Improving Early Alzheimers Detection in Women by Integrating Multimodal Data Into Clinical Decision Tools with Iris Broce-Diaz Ph.D.
0:23
0:47
0:52
1:04
1:16
1:27


Iris Broce-DiazGUEST
well thank you so much for inviting me yeah i'm iris and i'm in the department of neurosciences so um thank you for giving me the opportunity to talk like what for six seconds for the work that i'm doing and um So I have this grant that I just recently got awarded from the Wellcome Care Lead Program.

Iris Broce-DiazGUEST
And really, their whole focus is on Alzheimer's disease prevention in women.

Iris Broce-DiazGUEST
And so Alzheimer's disease is a progressive neurodegenerative condition that impairs your memory and cognition and affects millions of people worldwide.

Iris Broce-DiazGUEST
What I'm trying to do is develop these accessible, non-invasive, cost-effective tools that can help primary care and neurologists in an early detection of Alzheimer's disease.

Iris Broce-DiazGUEST
Really, to create a tool and deploy it in the clinics and make it accessible here and worldwide, we're starting with standard of care tools.

Iris Broce-DiazGUEST
um and so what's considered standard of care is very different in a high resource center versus a low resource center versus here versus latin america versus europe and that's really interesting but we are starting here at ucsd and diagnosing dementia really does start in primary care and so usually like a patient will report a concern or the family member And then the primary care, they don't have a lot of time, but they'll order some standard labs.
8 MINS LATER
S
10:11speaker_4PANELIST
How do we get it that standard so that this actually makes a difference?